IDEXX Laboratories shares fell 4.7% to $546.09 on June 17, 2026, leaving the stock near the lower end of its 52-week range of $506.91 to $769.98. The move appears to be a price-action update rather than a fundamental catalyst, with no additional company-specific news provided in the text.
IDEXX Laboratories shares fell 4.7% to $546.09 on June 17, 2026, leaving the stock near the lower end of its 52-week range of $506.91 to $769.98. The move appears to be a price-action update rather than a fundamental catalyst, with no additional company-specific news provided in the text.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
